ROSELLA (GOG3073, engotov72, APGOT-OV10): a phase 3 study of relacorilant + nab-paclitaxel in patients with platinum-resistant ovarian cancer

International Journal of Gynecological Cancer 2026

View at publisher
Authors: Domenica Lorusso, Stanislas Quesada, John K. Chan, Jung-Yun Lee, Mariana Scaranti, Vanda Salutari, Carolyn Y. Muller, Linda Mileshkin, Toon Van Gorp, Lyndsay J. Willmott, Ana Santaballa Bertrán, Elizabeth G. Munro
+8 more Saira Khalique, Nicoletta Colombo, Philippe Follana, Giuseppa Scandurra, Ròbert Póka, Hristina I. Pashova, Bhagyashree Yadav, Alexander B. Olawaiye
DOI: 10.1016/j.ijgc.2025.104426
Cited by: 1

Fields of Study & Subjects

Ovarian cancer diagnosis and treatment PARP inhibition in cancer therapy Estrogen and related hormone effects

Publication details

Journal / source
International Journal of Gynecological Cancer
Publisher
Elsevier BV
Volume
36
Issue
2
Pages
104426–104426
Publication date
1 February 2026
Language
EN